InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Parison Amy. Director active across 1 company, notably Editas Medicine, Inc.. Aggregated, 8 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €9k. History available since 3 June 2025. The latest transaction was disclosed on 3 September 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Parison Amy is a declarant linked to Editas Medicine, Inc. (XNAS), where she is SVP, Chief Financial Officer. She has 7 filings in total, and across the 7 sampled recent filings, the transactions are sales, for a sell amount of EUR 7463 between 2025-06-04 and 2026-08-05.